Article info
PDFWhat to do
When the first antiepileptic drug fails in a patient with juvenile myoclonic epilepsy
- Correspondence to Dr A Nicolson, The Walton Centre NHS Foundation Trust, Lower Lane, Fazakerley, Liverpool L9 7LJ, UK; andrew.nicolson{at}thewaltoncentre.nhs.uk
Citation
When the first antiepileptic drug fails in a patient with juvenile myoclonic epilepsy
Publication history
- First published July 20, 2010.
Online issue publication
April 14, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions
Other content recommended for you
- Managing childhood epilepsy
- New drugs for the treatment of epilepsy: a practical approach
- Juvenile myoclonic epilepsy: under-appreciated and under-diagnosed
- The new antiepileptic drugs
- Typical absence seizures and their treatment
- Diagnosis and management of the epilepsies in adults and children: summary of updated NICE guidance
- Treatment of difficult epilepsy
- Drug treatment of epilepsy in adults
- New drug treatments for epilepsy
- Clinical factors of drug resistance in juvenile myoclonic epilepsy